Alkaline Phosphatase: Does it have a Role in Predicting Hepatocellular Carcinoma Recurrence?
- 1 August 2011
- journal article
- Published by Elsevier BV in Journal of Gastrointestinal Surgery
- Vol. 15 (8), 1440-1449
- https://doi.org/10.1007/s11605-011-1537-3
Abstract
No abstract availableKeywords
This publication has 26 references indexed in Scilit:
- Clinical Advantage of Highly Sensitive On-Chip Immunoassay for Fucosylated Fraction of Alpha-Fetoprotein in Patients with Hepatocellular CarcinomaDigestive Diseases and Sciences, 2010
- Serum Markers of Hepatocellular CarcinomaDigestive Diseases and Sciences, 2010
- Fucosylated Fraction of Alpha-Fetoprotein as a Predictor of Prognosis in Patients with Hepatocellular Carcinoma After Curative TreatmentDigestive Diseases and Sciences, 2009
- Applicability of staging systems for patients with hepatocellular carcinoma is dependent on treatment method – Analysis of 2010 Taiwanese patientsEuropean Journal of Cancer, 2009
- Secular trends and geographic variations of hepatitis B virus and hepatitis C virus‐associated hepatocellular carcinoma in TaiwanInternational Journal of Cancer, 2006
- Liver Resection for Hepatocellular Carcinoma on CirrhosisAnnals of Surgery, 2003
- Nuclear localization of alkaline phosphatase in cultured human cancer cellsMedical Molecular Morphology, 2003
- Prognostic factors of hepatic resection for hepatocellular carcinoma with cirrhosis: Univariate and multivariate analysisJournal of Surgical Oncology, 2002
- Construction of the Chinese University Prognostic Index for hepatocellular carcinoma and comparison with the TNM staging system, the Okuda staging system, and the Cancer of the Liver Italian Program staging systemCancer, 2002
- Type beta transforming growth factor reversibly inhibits the early proliferative response to partial hepatectomy in the rat.Proceedings of the National Academy of Sciences of the United States of America, 1988